MOELIS & CO - CLASS A (MC)
US60786M1053 - Common Stock
ChartMill assigns a Buy % Consensus number of 44% to MC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.47. This target is 10.73% above the current price.
MC was analyzed by 16 analysts. The buy percentage consensus is at 44. So analysts seem to be rather negative about MC.
In the previous month the buy percentage consensus was at a similar level.
MC was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-25 | Keefe, Bruyette & Woods | Reiterate | Market Perform -> Market Perform |
| 2024-04-25 | UBS | Maintains | Sell -> Sell |
| 2024-04-09 | JMP Securities | Reiterate | Market Perform |
| 2024-03-26 | UBS | Maintains | Sell -> Sell |
| 2024-03-13 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2024-02-08 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-01-29 | Keefe, Bruyette & Woods | Reiterate | Market Perform |
| 2023-12-19 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-11-03 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-10-03 | UBS | Maintains | Sell -> Sell |
| 2023-07-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-12 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-06-27 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-04-27 | Keefe, Bruyette & Woods | Maintains | Underperform |
| 2023-04-12 | Morgan Stanley | Maintains | Underweight |
| 2023-03-24 | Goldman Sachs | Maintains | Sell |
| 2023-02-09 | Goldman Sachs | Maintains | Sell |
| 2023-01-11 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2023-01-09 | UBS | Maintains | Sell |
| 2022-11-03 | Keefe, Bruyette & Woods | Downgrade | Market Perform -> Underperform |
| 2022-11-03 | JP Morgan | Maintains | Neutral |
| 2022-10-07 | Goldman Sachs | Maintains | Neutral |
| 2022-09-23 | UBS | Downgrade | Neutral -> Sell |
| 2022-07-28 | UBS | Maintains | Neutral |
| 2022-07-18 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2022-07-11 | Wolfe Research | Downgrade | Peer Perform -> Underperform |
| 2022-07-08 | Piper Sandler | Maintains | Neutral |
| 2022-07-06 | UBS | Downgrade | Buy -> Neutral |
| 2022-04-28 | Piper Sandler | Downgrade | Overweight -> Neutral |